CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon

CMFRI, Library (2022) CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon. Aquaculture Spectrum, 5 (12). p. 66. ISSN 2581-7892

[img] Text
Aquaculture Spectrum_2022_Natural Product.pdf

Download (65kB)
Official URL: https://www.aquaoutlook.com/

Abstract

CadalminTM LivCure extract, a patent-protected nutraceutical product developed by the ICARCentral Marine Fisheries Research Institute (CMFRI) from seaweeds to combat non-alcoholic fatty liver disease (NAFLD) will hit the markets soon. CMFRI signed a Memorandum of Understanding (MoU) with M/s. Emineotech, a private limited company dealing with health products, for commercial production and marketing. Dr. A. Gopalakrishnan, Director of CMFRI signed a license agreement with Mr. Evanjalist Pathrose, Managing Director of Emineotech.

Item Type: Article
Uncontrolled Keywords: Seaweed; fatty liver disease
Subjects: Biochemistry
Algae > Seaweed
Divisions: Library and Documentation Centre
Depositing User: Arun Surendran
Date Deposited: 27 Sep 2010 07:37
Last Modified: 10 Mar 2023 11:20
URI: http://eprints.cmfri.org.in/id/eprint/4462

Actions (login required)

View Item View Item